PT-141 (Bremelanotide) Research Overview: MC4R-Focused Melanocortin Agonist
Bremelanotide (PT-141) is a cyclic melanocortin receptor agonist with FDA approval for hypoactive sexual desire disorder in premenopausal women. This guide covers its pharmacology, the focused clinical evidence, and how it differs from the broader Melanotan II.
Sections
Chemical Structure and Pharmacology
Mechanisms Studied in Research
Ready to explore our peptides?
Browse our full range of research-grade peptides with fast EU shipping.
Key Research Applications
Community Use vs Evidence Base
Storage and Regulatory Status
Stay up to date with peptide research
Get the latest research findings, product updates, and exclusive offers delivered to your inbox.
Ready to get started?
Browse our full range of research-grade peptides with fast EU shipping.